Skip to main content

Main menu

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • Audiovisual Rheum
    • COVID-19 and Rheumatology
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Author Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • Privacy/GDPR Policy
    • Accessibility
  • Contact Us
  • JRheum Supplements
  • Services

User menu

  • My Cart
  • Log In

Search

  • Advanced search
The Journal of Rheumatology
  • JRheum Supplements
  • Services
  • My Cart
  • Log In
The Journal of Rheumatology

Advanced Search

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • Audiovisual Rheum
    • COVID-19 and Rheumatology
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Author Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • Privacy/GDPR Policy
    • Accessibility
  • Contact Us
  • Follow jrheum on Twitter
  • Visit jrheum on Facebook
  • Follow jrheum on LinkedIn
  • Follow jrheum on YouTube
  • Follow jrheum on Instagram
  • Follow jrheum on RSS
LetterLetter

Perianal Crohn Disease after Treatment with Rituximab for Active Granulomatosis with Polyangiitis

DAVID FRASER, STEPHEN BOYLE and NICOLE AMFT
The Journal of Rheumatology December 2016, 43 (12) 2199-2200; DOI: https://doi.org/10.3899/jrheum.160456
DAVID FRASER
Rheumatology Department, Western General Hospital;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
STEPHEN BOYLE
Rheumatology Department, Western General Hospital;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: boyledoc@yahoo.co.uk
NICOLE AMFT
Rheumatology Department, Western General Hospital, Edinburgh, UK.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • References
  • Info & Metrics
  • PDF
  • eLetters
PreviousNext
Loading

Article Information

vol. 43 no. 12 2199-2200
DOI 
https://doi.org/10.3899/jrheum.160456
PubMed 
27909145

Published By 
The Journal of Rheumatology
Print ISSN 
0315-162X
Online ISSN 
1499-2752
History 
  • Published online December 1, 2016.

Copyright & Usage 
© 2016

Author Information

  1. DAVID FRASER, MBCHB
  1. Rheumatology Department, Western General Hospital;
  1. STEPHEN BOYLE, MRCP⇑
  1. Rheumatology Department, Western General Hospital;
  1. Address correspondence to Dr. S. Boyle, Rheumatology Department, Western General Hospital, Crewe Road South, Edinburgh EH4 2XU, UK. E-mail: boyledoc{at}yahoo.co.uk
  1. NICOLE AMFT, FRCP
  1. Rheumatology Department, Western General Hospital, Edinburgh, UK.

Article usage

Article usage: November 2016 to April 2022

AbstractFullPdf
Nov 2016051
Dec 2016678261
Jan 2017506951
Feb 2017245220
Mar 2017223011
Apr 2017111912
May 2017141813
Jun 20171148
Jul 201793516
Aug 201731412
Sep 201752019
Oct 201751419
Nov 201762633
Dec 201711514
Jan 201862713
Feb 201864024
Mar 201865127
Apr 201853223
May 201833228
Jun 201842517
Jul 2018101714
Aug 2018211618
Sep 201853716
Oct 201845135
Nov 201825622
Dec 201813214
Jan 201924331
Feb 201932422
Mar 201913034
Apr 201922236
May 201942434
Jun 201902631
Jul 201912625
Aug 201912113
Sep 201921914
Oct 201923030
Nov 201922321
Dec 20191259
Jan 20200218
Feb 202032711
Mar 20200158
Apr 20200288
May 202001211
Jun 202031813
Jul 202002413
Aug 202021515
Sep 20202155
Oct 202071312
Nov 202031412
Dec 202003313
Jan 20211205
Feb 20211368
Mar 20212309
Apr 20210348
May 20211223
Jun 202122511
Jul 20211184
Aug 20211238
Sep 20210199
Oct 202122023
Nov 202101316
Dec 20211216
Jan 20220314
Feb 20220265
Mar 20222174
Apr 20220405

Statistics from Altmetric.com

PreviousNext
Back to top

In this issue

The Journal of Rheumatology
Vol. 43, Issue 12
1 Dec 2016
  • Table of Contents
  • Table of Contents (PDF)
  • Index by Author
  • Editorial Board (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about The Journal of Rheumatology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Perianal Crohn Disease after Treatment with Rituximab for Active Granulomatosis with Polyangiitis
(Your Name) has forwarded a page to you from The Journal of Rheumatology
(Your Name) thought you would like to see this page from the The Journal of Rheumatology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Perianal Crohn Disease after Treatment with Rituximab for Active Granulomatosis with Polyangiitis
DAVID FRASER, STEPHEN BOYLE, NICOLE AMFT
The Journal of Rheumatology Dec 2016, 43 (12) 2199-2200; DOI: 10.3899/jrheum.160456

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

 Request Permissions

Share
Perianal Crohn Disease after Treatment with Rituximab for Active Granulomatosis with Polyangiitis
DAVID FRASER, STEPHEN BOYLE, NICOLE AMFT
The Journal of Rheumatology Dec 2016, 43 (12) 2199-2200; DOI: 10.3899/jrheum.160456
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • REFERENCES
  • Figures & Data
  • References
  • Info & Metrics
  • PDF
  • eLetters

Related Articles

Cited By...

More in this TOC Section

  • Some Key Issues Relating to the Reporting and Interpretation of Time-to-event Data
  • Dr. Griffiths et al reply
  • Baricitinib for Refractory Eosinophilic Fasciitis: Myth or Reality?
Show more Letter

Similar Articles

Content

  • First Release
  • Current
  • Archives
  • Collections
  • Audiovisual Rheum
  • COVID-19 and Rheumatology

Resources

  • Guide for Authors
  • Submit Manuscript
  • Author Payment
  • Reviewers
  • Advertisers
  • Classified Ads
  • Reprints and Translations
  • Permissions
  • Meetings
  • FAQ
  • Policies

Subscribers

  • Subscription Information
  • Purchase Subscription
  • Your Account
  • Terms and Conditions

More

  • About Us
  • Contact Us
  • My Alerts
  • My Folders
  • Privacy/GDPR Policy
  • RSS Feeds
The Journal of Rheumatology
The content of this site is intended for health care professionals.
Copyright © 2022 by The Journal of Rheumatology Publishing Co. Ltd.
Print ISSN: 0315-162X; Online ISSN: 1499-2752
Powered by HighWire